Location |
Symbol |
Title |
MIM # |
Disorder |
Comments |
Method |
Mouse |
17q25 |
EVPL |
Envoplakin |
601590 |
|
|
REa, A |
|
17q25 |
FASN |
Fatty acid synthase |
600212 |
|
|
A |
|
17q25 |
FN3KRP |
Fructosamine 3-kinase-related protein |
611683 |
|
|
REc |
|
17q25 |
FSCN2, RFSN, RP30 |
Fascin, sea urchin, homolog of, 2 |
607643 |
Retinitis pigmentosa-30, 607921 (3) |
within 200kb of ACTG1 |
A, REc |
|
17q25 |
PSORS2, PSS1 |
Psoriasis susceptibility 2 |
602723 |
{Psoriasis, susceptibility to}, 177900 (2) |
about 50% of families linked to 17q; not confirmed by some |
Fd |
|
17q25 |
GCGR |
Glucagon receptor |
138033 |
{Diabetes mellitus, noninsulin-dependent}, 125853 (3) |
|
A, Fd |
|
17q25 |
GRIN2C, NMDAR2C |
Glutamate receptor, ionotropic, N-methyl D-aspartate 2C |
138254 |
|
|
A |
|
17q25 |
H3F3B |
H3 histone, family 3B (H3.3B) |
601058 |
|
|
A |
|
17q25 |
HGS, HRS |
Human growth factor-regulated tyrosine kinase substrate |
604375 |
|
|
REa, A |
|
17q25 |
ILF1 |
Interleukin enhancer-binding factor 1 |
147685 |
|
|
REa, A |
|
17q25 |
JMJD6, PSR |
Jumonji domain containing 6 (phosphatidylserine receptor) |
604914 |
|
|
REc |
|
17q25 |
KCNJ16, KIR5.1 |
Potassium channel, inwardly rectifying, subfamily J, member 16 |
605722 |
|
|
R |
|
17q25 |
LGALS3BP |
Lectin, galactoside-binding, soluble, 3 binding protein (galectin 6 binding protein) |
600626 |
|
|
A |
11(Lgals3bp) |
17q25 |
MAFG |
v-maf avian musculoaponeurotic fibrosarcoma oncogene family, protein G |
602020 |
|
|
A |
|
17q25 |
MYMY2 |
Moyamoya disease 2 |
607151 |
Moyamoya disease 2 (2) |
?3p26; between D17S785 and D17S836 |
Fd |
|
17q25 |
P4HB, PROHB |
Procollagen-proline, 2-oxoglutarate-4-dioxygenase, beta polypeptide; thyroid hormone-binding protein p55 |
176790 |
|
|
S, REa, A, C |
|
17q25 |
PDE6G, PDEG |
Phosphodiesterase-6G, cGMP-specific, rod, gamma |
180073 |
|
|
REa, A, Fd |
11(Pdeg) |
17q25 |
PCNT1, PCNT |
Pericentrin 1 |
170285 |
|
|
REc |
|
17q25 |
RECQL5, RECQ5 |
DNA helicase, RecQ-like, type 5 |
603781 |
|
|
A |
|
17q25 |
RFNG |
Radical fringe |
602578 |
|
|
REa |
11(Rfng) |
17q25 |
SEPT9, MSF, MSF1, NAPB |
Septin 9 |
604061 |
Leukemia, acute myeloid, therapy-related (1); Ovarian carcinoma (1);Amyotrophy, hereditary neuralgic, 162100 (3) |
|
Ch, REa, Fd |
|